Voyager Therapeutics
Aadhar Mahajan is an accomplished professional in R&D program and project management, currently serving as Associate Director at Voyager Therapeutics, Inc. Since August 2025, Aadhar has garnered extensive experience in the biopharmaceutical industry, with prior roles including Associate Director of Project Management at Keros Therapeutics and Associate Director of Program Management at Immunovant. Aadhar's expertise spans various aspects of clinical trial management, including the development of project management tools and leading initiatives for IND submissions. Previous positions include Senior Manager at Avenge Bio, where Aadhar managed a cell therapy start-up, and Manager of Portfolio & Program Management at Sigilon Therapeutics, facilitating successful regulatory filings. Aadhar holds an MBA from Boston University and a B.S. in Biology with a minor in Economics from Boston College.
This person is not in any teams
This person is not in any offices
Voyager Therapeutics
1 followers
Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases.